PR Newswire Government
pressCenter
BioViva Announces U.S. Patent for Klotho Gene Therapy Targeting Age-Related Cognitive Declinetranslating…
Patent No. 12,564,646 Covers the Use of Klotho and hTERT Gene Therapy for Age-Related Cognitive Decline BAINBRIDGE ISLAND, Wash., Sept. 1, 2026 /PRNewswire/ -- BioViva USA, Inc., a biotechnology company developing therapies targeting the biological mechanisms of aging, today…
Keywords#Age-Related Cognitive#Cognitive Decline#Gene Therapy#BioViva#Klotho